Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039070 | SCV000062748 | benign | not specified | 2012-07-17 | criteria provided, single submitter | clinical testing | 6.7% (295/4402) of Afr Amer chrom from ESP |
Gene |
RCV000039070 | SCV000169889 | benign | not specified | 2013-05-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000039070 | SCV000313862 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000345734 | SCV000402718 | likely benign | Arrhythmogenic right ventricular dysplasia 12 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000397634 | SCV000402719 | likely benign | Naxos disease | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
ARUP Laboratories, |
RCV001529638 | SCV001157599 | benign | not provided | 2023-10-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002054496 | SCV002453496 | benign | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001841526 | SCV000052751 | benign | Cardiac arrhythmia | 2015-05-20 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV001529638 | SCV001743432 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000039070 | SCV001919224 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000039070 | SCV001926604 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000039070 | SCV001952139 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000039070 | SCV001970786 | benign | not specified | no assertion criteria provided | clinical testing | ||
Cohesion Phenomics | RCV003125838 | SCV003802975 | benign | Cardiomyopathy | 2022-09-23 | no assertion criteria provided | clinical testing |